Endometriosis Awareness Month, March 2024

Endometriosis is a chronic, estrogen-dependent condition where tissue similar to the lining inside the uterus, known as endometrium, grows outside the uterine cavity. This aberrant tissue growth can occur on the ovaries, fallopian tubes, pelvic lining, and other areas, leading to pain, infertility, and other complications. It was first clearly described in 1860, but symptoms consistent with the condition were mentioned in texts 4000 years ago. Epidemiologically, endometriosis affects 10% of women of reproductive age, 176 million women worldwide. The condition is most commonly diagnosed in women in their 30s and 40s, although it can occur in any female post-puberty. Management of endometriosis includes a combination of pharmacological and surgical options. Medications like nonsteroidal anti-inflammatory drugs (NSAIDs), hormonal therapies, and gonadotropin-releasing hormone (GnRH) analogs are used to manage symptoms. In more severe cases, surgical interventions, including laparoscopy, may be necessary to remove endometrial lesions and improve fertility. The impact of endometriosis is multifaceted, affecting physical, mental health and quality of life. The condition also imposes economic burdens due to healthcare costs and lost productivity. Psychologically, it can lead to anxiety, depression, and other emotional stressors, emphasizing the need for comprehensive care and support for affected individuals. https://en.wikipedia.org/wiki/Endometriosis Art&Text🫶ChatGPT.